BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7543414)

  • 1. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
    Ferrero D; Tarella C; Cherasco C; Bondesan P; Omedè P; Ravaglia R; Caracciolo D; Castellino C; Pileri A
    Bone Marrow Transplant; 1998 Feb; 21(4):409-13. PubMed ID: 9509977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation.
    Negrin RS; Kusnierz-Glaz C; Blume KG; Strober S
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S31-3. PubMed ID: 8722331
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.
    Almici C; Carlo-Stella C; Mangoni L; Garau D; Cottafavi L; Ventura A; Armanetti M; Wagner JE; Rizzoli V
    Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
    Silva MR; Parreira A; Ascensão JL
    Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
    Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
    Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and characterization of mobilized and unmobilized peripheral blood progenitor cells by counterflow centrifugal elutriation.
    Grimm J; Zeller W; Zander AR
    Exp Hematol; 1995 Jun; 23(6):535-44. PubMed ID: 7539381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
    Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S
    Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative comparative analysis of gradient-separated hematopoietic cells from cord blood and chemotherapy-mobilized peripheral blood.
    Sato J; Kawano Y; Takaue Y; Hirao A; Makimoto A; Okamoto Y; Abe T; Shimokawa T; Iwai A; Kuroda Y
    Stem Cells; 1995 Sep; 13(5):548-55. PubMed ID: 8528105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors.
    Shier LR; Schultz KR; Imren S; Regan J; Issekutz A; Sadek I; Gilman A; Luo Z; Panzarella T; Eaves CJ; Couban S
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):624-34. PubMed ID: 15319774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.